Ahmad Sajjadi, MD, PhD, UCI Neurologist and UCI MIND faculty member, was quoted in Healthline regarding the recent announcement by FDA to delay the decision to approve Eli Lilly’s amyloid…
Đọc thêm
UCI MIND faculty member and UCI Neurologist, Ahmad Sajjadi, MD, PhD, awarded UCI Institute for Precision Health Pilot Award. Dr. Sajjadi will work with Tianchen Qian, PhD, a REC trainee…
Đọc thêm
The FDA today announced that it will convene an advisory panel to review the data submitted to support potential approval of donanemab, a monoclonal antibody against the beta amyloid protein…
Đọc thêm
Message from the Director Dear Friends of UCI MIND, Happy New Year! We hope that 2024 is off to a positive start for you. As we embark upon a new…
Đọc thêm
Ahmad Sajjadi, MD, PhD, a UCI Neurologist and UCI MIND faculty member was interviewed live on NBC Los Angeles about the recent announcement that talk show host Wendy Williams…
Đọc thêm
Biogen, the maker of aducanumab has announced that it will terminate the Phase 4 trial required by the FDA for aducanumab, the monoclonal antibody against beta amyloid that received accelerated…
Đọc thêm
The medications have not been widely tested in Black people with the disease, underscoring stark — and persistent — disparities ABINGTON, Pa. — Wrapped in a purple blanket, Robert Williford…
Đọc thêm
In the first study of its kind in humans, researchers have discovered that it is safe to use sound waves fired into specific areas of the brain to open a…
Đọc thêm
TAMPA (BLOOM) – Join us as we explore strategies—from mindful living to emerging technologies—and discover how every choice can lead to a longer and healthier life. Welcome to the science of…
Đọc thêm
Dr. Joshua Grill, Director of UCI MIND is named one of Orange County’s 125 most influential people for 2023 by the Orange County Register! Read article here The post UCI…
Đọc thêm